Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma. (scientific article published in May 2010)

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

Q36629194

Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

Q37143660

Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization

Q38457830

GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma

Q39915264

Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

Q39949741

Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

Q40330626

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

Q40479135

Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.

Q40792693

The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis

Q42040698

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

Q44135718

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

Q44730863

Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions

Q51597461

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors

Q53356360

Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?

Q54633278

High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization.

Q54712062

Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH.

Q55044634

Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma

Q61312160

Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma

Q61312250

Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci

Q61312332

t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia

Q73459806

Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma

Q74480204

Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma

Q77220569

Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene

Q77495202

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma

Q79426028

Sequential fluorescence in situ hybridisation analysis for cryptic t(11;14)(q13;q32) in mantle cell lymphoma

Q79759352

Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma

Q80442153

Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region

Q80593091

Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization

Q80894677

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis

Q81481033

P433

issue

P304

page(s)

439-451

P577

publication date

2010-05-01

P1433

published in

Genes, Chromosomes and Cancer

Q5532697

P1476

title

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

P478

volume

Reverse relations

cites work (P2860)

Q57759536	A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Q42717293	A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report
Q34868444	Blastoid variant mantle cell lymphoma with complex karyotype including 11q duplication
Q35252948	Clinicopathologic features of 112 cases with mantle cell lymphoma
Q90237291	Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Q52341659	Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Q48505196	Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Q39875737	Expanding probe repertoire and improving reproducibility in human genomic hybridization.
Q90459519	Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Q85004110	Guidelines for the investigation and management of mantle cell lymphoma
Q46409191	High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma
Q36561781	High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
Q34188267	Iodothyronine deiodinases and cancer
Q51529244	Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.
Q54215492	Mantle cell lymphoma harboring Burkitt's-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities.
Q33917671	Mantle cell lymphoma with features of marginal-zone lymphoma
Q38571854	Mantle cell lymphoma--a spectrum from indolent to aggressive disease
Q47624912	Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status
Q85407330	Pitfalls and update in haematopathology. Case 3. Mantle cell lymphoma, aggressive variant, pleomorphic
Q64107536	Pleomorphic Mantle Cell Lymphoma of the Tongue Base Presenting With Dysphagia
Q37062711	Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
Q26858960	Risk factors for etiology and prognosis of mantle cell lymphoma
Q44418379	TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage
Q37781972	The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas
Q37938600	Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: Implications for the origin and selection of the malignant cells